{"member_organisations": "", "identification_number": "37955905654-37", "fields_of_interest": "General and Institutional Affairs, Trade, Competition, Consumers, Employment and Social Affairs, Business and Industry, Taxation, Single market, Research and innovation, Public Health", "head_office_address": "Morris Avenue, 86", "full_time_equivalent_fte": "2,5", "person_with_legal_responsibility": "Mark Alles", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "Celgene works with European institutions to raise awareness of diseases with a high unmet medical need - such as rare diseases, rare cancers and immune and inflammatory diseases - to drive greater focus on patients with these underserved conditions. We seek cooperation in policy developments that improve regulatory processes for pharmaceuticals and ensure the right environment for research and industry in Europe. We foster debates around improved and equal access to innovative medicines for patients through open dialogues with European policy-makers. \n \nWe therefore monitor EU initiatives related to the registration and evaluation of medicines as well as the current EU policy debates on innovation in healthcare, Health Technology Assessment cooperation, access to medicines and intellectual property.", "level_of_interest": "global", "organisation_name": "CELGENE", "belgium_office_post_code": "1050", "number_of_persons_involved": "5", "person_in_charge_of_eu_relations": "Emmanuel Chantelot", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "(+32)28949061", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "Rue du Tr\u00f4ne, 108", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "Chantelot#Emmanuel, Gicquel#Erwan, PARNABY#Adam, POPA#Silviu, Sergent#Cassandre", "registration_date": "14/04/2011", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.celgene.com/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Summit", "membership": "Celgene is a member of following organizations in Brussels: \nEuropean Federation of Pharmaceutical Industries and Associations (EFPIA) \nEuropean Confederation of Pharmaceutical Entrepreneurs (EUCOPE) \nAmerican Chamber of Commerce to the European Union (AmCham EU) \nFriends of Europe \nEuropean Policy Center", "head_office_post_code": "NJ07901", "position": "Executive Director, Government Relations and Policy, Worldwide Markets", "financial_year_start_date": "01/01/2017", "head_office_country": "United States", "number_of_ep_accredited_persons": "5", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "400000-499999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation - publicly traded", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.", "belgium_office_city": "Bruxelles", "head_office_phone": "(+01)9086739000"}